: iStockAnalyst.com Symbols Feed

Friday Stock Fun: Where Are The Profits?

Fri, 17 Oct 2008 16:43:00 GMT

After the record setting daily swings in the stock markets over the last few weeks I was curious about how many stock still have excellent gains for the year. Scanning through the stock tables shows the vast majority of stocks are in negative territory[More...]

20 Stocks On My Morning Watchlist, Not All Potential Shorts, A Potential Breakout Too!

Tue, 23 Sep 2008 16:40:00 GMT

This went out to TIMalert subscribers early this morning: Good job Pallian, the chat is now up and running on TIMalerts.com, for subscribers-only. Look in the upper right hand corner…Those who aren’t subscribed, click it and see what happens, I dare ya! Just give in already, signup HERE Getting some weird emails/comments from you guys expecting solid trade setups every day and expecting me to profit every single day. That’s not the way trading works and it’s certainly not the way I work. Lay off the absinthe guys, legal or not, it screw you up. My trading account is up 120%+ in the last 10 months—7% this month–even while I make tons of mistakes cuz I just take it one pump at a time. I don’t judge them as being too illiquid or happening too fast, I[More...]

Thirteen Penny Stocks That Are In Play

Tue, 09 Sep 2008 14:43:00 GMT

TIMlerts peeps got this at 1am this morn:Still no perfect setups, took me a decade, but I’ve got patience….if you’re gonna be a successful PennyStocker, you better learn patience too cuz there just aren’t great setups every day for big 20%+ predictable moves.UAUA took a big intraday dive on bankruptcy rumors/misinformation, someone’s gonna pay for that screw up…good news is some TIMalert peeps shorted and covered fro quick profit..I didn’t even think about it, I hate rumors and fast dives, I prefer fades…much better for TIMalert subscribers too, don’t wanna go short at the bottom and then find the stock halted, only to reopen up $5+!FNM/FRE donwtrended then bounced a bit…people wondering why don’t play em don’t have my PennyStocking DVD. People, I play pump and dumps[More...]

Eleven Stocks to Consider for Short Selling

Tue, 19 Aug 2008 15:22:00 GMT

One day before my awesome Japan trip (detailed itinerary post coming later today…brutal honesty baby!), gotta get everything in order cuz when I’m there I’m not gonna be able to read shit! Some decent plays nonetheless:FOUR I thought would be good for a bounce yesterday, was dead wrong, even though I said it was “risky, risky, risky, risky” and it still went up 10% from my TIMalert, many got in too late and lost…I took a $300ish loss…detailed post coming, no way in hell should anybody be buying this thing, it’s for the vultures now.RDN keeps going, bouncy 25-50 cents/share here and there, still not a suitable pattern for meSTAA I mentioned several days ago, but before it really started spiking…gradual mover turning volatile, watch out, let’s see how far it goesBHBC is a spiking bank with the chart of a pump and[More...]

Nine Stocks Eventually to Short Sell

Mon, 18 Aug 2008 14:36:00 GMT

Weird weekend—no video shoot on Saturday due to family emergency, guess this video is just cursed…nah we’ll do it when I get back from Japan…speaking of, it’s consuming all my time as I leave this Wednesday…don’t worry, got my entire trip planned around internet cafes, girlfriend not gonna be happy, but TIMalert subscribers will be!ZYXI just keeps going higher and now it’s an earnings play. God love em…longs beware, I think this runup is being constructed, no different than APII, FEED, all the little crap companies that wanna raise $/use their stock for acquisitions…its magnificient artwork…their latest earnings report hints: … (visit site to read[More...]

Twenty Stocks To Watch today

Tue, 12 Aug 2008 14:56:00 GMT

Quantum Fuel Systems Technologies (QTWW) found support at $1.50, now trying to bounce back to former highs, tough, tough pattern to bounce back from, nice little 15 cent scalp off the morning highs yesterday, possible retrace to $1.90ish, not worth short for me here, I hope it goes higherFEED dropped $1+ after I posted THIS yesterday…I’m glad several of you banked off it, these guys are such scum it’s not even funny. Now it’s gone up, its dropped, its dead to me.NOBL acted fairly predictably, trying to hold the $4.80-$4.90 support, dropping but not collapsing…told ya sooooo! Now its really dead to me, stop losses have been taken out, it’ll probly just be bouncy, bye bye Ms. Solid earnings pie.Xerium Technologies, Inc. (XRM) is my #1 potential buy, just[More...]

Take a Look at These Thirteen Stocks

Thu, 07 Aug 2008 15:28:00 GMT

I know, I know you want some stock trades, well, it’s been boring, welcome to PennyStocking, there’s not gonna be a trade every day or even every week, especially during this, the slowest month of the year. Deal with it and don’t force trades…and most of all, stop emailing me about when … (visit site to read more)[More...]

To Short Sell These 10 Stocks…Or Not?

Wed, 06 Aug 2008 14:35:00 GMT

Yes, some old guy opened his mouth yesterday and the business world shook. I don’t care about the Fed, nor the overall markets, I search for individual pump and dumps. I am glad the markets rebounded, but only because that gets our favorite spammers/pumpers in a better mood to do the only thing they’re good at…and that’s when PennyStocking is so awesome…so if this rally continues, expect some solid plays to open up…as it is, I don’t see anything worth anyone’s time, other than if you’re a scalper and if you are, I pity you, it’s no way to live.PGTI is now up 50% in 4 days, earnings play, inverse head and shoulders, looks great, but still a ton of bitter shareholders, I’d love for it to keep going, if it can break $6…convincingly, no real resistance til the high $7s, which would be a great entry point to try to go for a $1-2 reversal…oh, this short seller is probly just[More...]

Premarket Report

Thu, 15 May 2008 13:35:37 GMT

Good morning. We're starting out the day with a positive bias amid some restructuring news at General Electric (GE) and a proxy battle at Yahoo! (YHOO). On the economic front, investors didn't show much reaction to a slightly higher than expected jobless[More...]

Looking For The Retest

Wed, 06 Feb 2008 16:27:24 GMT

Good morning. Traders are hoping for a Wednesday bounce following yesterday's meltdown.[More...]

Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise

Mon, 18 May 2009 11:25:00 GMT

Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise[More...]

Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise

Mon, 18 May 2009 07:55:00 GMT

Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise[More...]

IDM Pharma Reports First Quarter Financial Results - May 11 2009 7:57AM

Mon, 11 May 2009 11:52:00 GMT

IRVINE, Calif., May 11 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. today reported financial results for the quarter ended March 31, 2009.
Cash and cash equivalents was $7.4 million as of March 31, 2009 compared to $12.8 million on December 31, 2008.
The decrease was primarily due to a $0.8 million reduction in spending related to clinical development of UVIDEM, which we placed on hold in December 2007 following sanofi-aventis' notification that it was discontinuing its participation in the development of the program, $0.2 million in savings due to the closing of our Paris facility, and $0.2 million of decreased spending associated with development activities related to products currently on hold, partially offset by higher spending of $0.3 million related to regulatory filings and manufacturing of MEPACT clinical supplies for our compassionate use program.

[More...]

IDM Pharma Reports First Quarter Financial Results

Mon, 11 May 2009 11:26:00 GMT

IDM Pharma, Inc. today reported financial results for the quarter ended March 31, 2009. Financial information presented represents the consolidated results of IDM Pharma, Inc. and its subsidiary, IDM Pharma S.A.[More...]

IDM Pharma Receives Nasdaq Shareholder Equity Notification

Mon, 13 Apr 2009 11:26:00 GMT

IDM Pharma, Inc. , a company focused on the development of innovative cancer products, including MEPACT , which was recently approved in Europe for the treatment of osteosarcoma, today announced receipt of a letter from the Listing Qualifications Department of the Nasdaq Stock Market informing the Company that it does not comply with the requirement to maintain a minimum of $10 million in stockholders' equity for continued listing on the Nasdaq Global Market.[More...]

IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 Fiscal Year Containing Audit Opinion With Going Concern Qualification

Fri, 03 Apr 2009 11:25:00 GMT

IDM Pharma, Inc. , a company focused on the development of innovative cancer products, including MEPACT , which was recently approved in Europe for the treatment of osteosarcoma, today announced that its financial statements for the fiscal year ended December 31, 2008, included in the Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 31, 2009, contain a going concern qualification from its independent registered public accounting firm.[More...]

IDM Pharma Reports 2008 Financial Results

Tue, 31 Mar 2009 11:26:00 GMT

IDM Pharma, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2008. Financial information presented represents the consolidated results of IDM Pharma, Inc. and its subsidiary, IDM Pharma S.A.[More...]

IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma

Mon, 09 Mar 2009 15:22:00 GMT

First New Agent Approved to Treat Osteosarcoma in More Than 20 Years[More...]

IDM Pharma Joins NORD to Raise Awareness of Rare Diseases

Thu, 26 Feb 2009 11:58:00 GMT

IDM Pharma, Inc. today announced that it is joining the National Organization for Rare Disorders and more than 100 patient organizations, caregivers, researchers and companies developing treatments for rare diseases to observe Rare Disease Day on February 28. The goal of the day is to bring attention to rare diseases, the challenges encountered by those affected and the importance of research to develop diagnostics and treatments. IDM Pharma is currently developing mifamurtide for the treatment of osteosarcoma, a rare bone cancer in children and young adults.[More...]

IDM Pharma Provides Update on Mifamurtide (MEPACT(R), L-MTP-PE) European Regulatory Status

Thu, 18 Dec 2008 17:28:00 GMT

IDM Pharma, Inc. today announced that the Committee for Medicinal Products for Human Use formally adopted a positive opinion for mifamurtide , known as MEPACT in Europe, for the treatment of patients with non- metastatic, resectable osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults. The formal adoption of the positive opinion follows the CHMP recommendation previously announced in November. The marketing authorization is likely to be issued by the European Commission in Q1 2009.[More...]